Understanding how latent viruses reactivate could unlock new strategies for managing chronic infections that affect billions worldwide. Epstein-Barr virus, which infects over 95% of adults and remains dormant in B cells, periodically awakens to cause tissue damage and potentially drive certain cancers. A breakthrough single-cell analysis technique now reveals the precise molecular choreography of this reactivation process. Researchers developed morphologic pseudotime screening to track individual infected cells as EBV transitions from dormancy to active replication. This approach captured the virus hijacking cellular DNA repair machinery while simultaneously triggering host damage responses. The study identified specific kinetic phases where viral proteins systematically dismantle cellular defenses before commandeering replication resources. Key findings include the temporal sequence of viral gene expression and the cellular stress checkpoints that either contain or fail to prevent viral takeover. This granular view of host-virus dynamics represents a significant methodological advance in virology. Previous studies could only observe population averages, missing the heterogeneous responses that determine infection outcomes. The single-cell resolution reveals why some cells successfully resist reactivation while others succumb. For health-conscious adults, this research illuminates the ongoing molecular battle occurring within latently infected cells. While EBV typically remains controlled by immune surveillance, stress, aging, or immunosuppression can tip the balance toward reactivation. Understanding these cellular decision points may eventually inform targeted interventions to prevent virus-associated diseases, including certain lymphomas and autoimmune conditions linked to EBV reactivation.